Literature DB >> 14504023

Brief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizations.

Eric Granholm1, Robert Anthenelli, Rita Monteiro, John Sevcik, Marilyn Stoler.   

Abstract

A retrospective pilot study was conducted to determine whether a relatively brief integrated outpatient treatment for patients with dual disorders reduced inpatient hospital service utilization. Outpatients (n=44) with substance dependence and either comorbid schizophrenia, major depressive disorder, or bipolar disorder were studied. A multidisciplinary team provided relatively brief (up to 24 weeks), integrated, dual-diagnosis outpatient treatment. A significant 60% reduction in the number of psychiatric hospitalization days was found for the year after treatment as compared to the year before. Patients with schizophrenia showed the greatest reduction (74%) in hospitalization days. Thus, even brief integrated outpatient dual-diagnosis treatment can reduce inpatient psychiatric hospitalizations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504023

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  7 in total

1.  Service utilization during and after outpatient treatment for comorbid substance use disorder and depression.

Authors:  Matthew J Worley; Ryan S Trim; Susan R Tate; Jessica E Hall; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2010-07-03

Review 2.  [Evidence basis of psychotherapy for schizophrenia patients in Germany].

Authors:  B Puschner; R Vauth; F Jacobi; T Becker
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

3.  Classes of substance abuse relapse situations: a comparison of adolescents and adults.

Authors:  Danielle E Ramo; Sandra A Brown
Journal:  Psychol Addict Behav       Date:  2008-09

Review 4.  Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis.

Authors:  Ramani Durvasula; Theodore R Miller
Journal:  Behav Med       Date:  2014       Impact factor: 3.104

Review 5.  Schizophrenia: a systemic disorder.

Authors:  Brian Kirkpatrick; Brian Miller; Clemente García-Rizo; Emilio Fernandez-Egea
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-07

Review 6.  Approaches to improve adherence to pharmacotherapy in patients with schizophrenia.

Authors:  Kimberly M Shuler
Journal:  Patient Prefer Adherence       Date:  2014-05-14       Impact factor: 2.711

7.  Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression.

Authors:  Veer Vekaria; Budhaditya Bose; Sean M Murphy; Jonathan Avery; George Alexopoulos; Jyotishman Pathak
Journal:  Transl Psychiatry       Date:  2021-05-03       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.